FlexiLingo
Will the AI labs eat everything or is tech just too sure of itself to tell what actually lasts? This week, Compound's Michael Dempsey explains why he invests against the herd in a market running on FOMO. We explore which SaaS companies survive AI, why sentiment has turned against tech, his case for a historic decade in bio, and why crypto venture went quiet while onchain assets got interesting. Enjoy! TIMESTAMPS: 00:00 Intro 01:29 How Do You Invest Without FOMO? 08:30...
Für diese Folge gibt es noch kein Transkript
Sie können sie trotzdem im Player anhören. Bei Folgen mit Transkript tippen Sie auf ein Wort, um seine Bedeutung zu sehen.